Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Dodwell

Showing results (21-30 of 119) with videos related to

Pageof 12
Sort By:
Breast (Edinburgh, Scotland)|October 2, 2014
Risk of subsequent invasive breast cancer after a diagnosis of ductal carcinoma in situ (DCIS)Shan Cheung, Mary E Booth, Olive Kearins, et al.
Radiology|May 23, 2018
Human Epidermal Growth Factor 2-positive Breast Cancer with Mammographic Microcalcification: Relationship to Pathologic Complete Response after Neoadjuvant ChemotherapyFayyaz A K Mazari, Nisha Sharma, David Dodwell, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 24, 2014
Axillary treatment in women with one or two sentinel nodes with macrometastases: more evidence is needed to inform practiceAmit Goyal, David Dodwell, Malcolm W Reed, et al.
BMJ (Clinical Research Ed.)|May 19, 2018
Should patients with ductal carcinoma in situ be treated with adjuvant whole breast radiotherapy after breast conservation surgery?Jessamy Bagenal, Nicola Roche, Gill Ross, et al.
Breast (Edinburgh, Scotland)|March 16, 2005
The oligometastatic state in breast cancer: hypothesis or realityCatherine R Tait, Alison Waterworth, Juliette Loncaster, et al.
Breast Cancer Research and Treatment|February 17, 2010
Aromatase inhibitor-induced arthralgia in early breast cancer: what do we know and how can we find out more?Omar S Din, David Dodwell, Richard J Wakefield, et al.
The Lancet. Oncology|November 5, 2020
Residual disease after mastectomyNigel J Bundred, David Dodwell, James R Bundred, et al.
Journal of Geriatric Oncology|July 8, 2023
Patterns of chemotherapy use and outcomes in advanced non-small cell lung cancer by age in England: A retrospective analysis of the population-based Systemic Anti-Cancer Treatment (SACT) datasetSophie Pilleron, Eva J A Morris, David Dodwell, et al.
NPJ Breast Cancer|March 30, 2025
Mapping the current landscape of locoregional therapy de-escalation trials in early breast cancer: a systematic reviewAlan D McCrorie, Hilary Stobart, David Dodwell, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|January 21, 2026
Reducing locoregional treatments in low risk early invasive breast cancerShelley Potter, Mairead MacKenzie, Stuart McIntosh, et al.
Pageof 12

Showing results (21-30 of 119) with videos related to

Sort By:
Pageof 12
Breast (Edinburgh, Scotland)|October 2, 2014
Risk of subsequent invasive breast cancer after a diagnosis of ductal carcinoma in situ (DCIS)Shan Cheung, Mary E Booth, Olive Kearins, et al.
Radiology|May 23, 2018
Human Epidermal Growth Factor 2-positive Breast Cancer with Mammographic Microcalcification: Relationship to Pathologic Complete Response after Neoadjuvant ChemotherapyFayyaz A K Mazari, Nisha Sharma, David Dodwell, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 24, 2014
Axillary treatment in women with one or two sentinel nodes with macrometastases: more evidence is needed to inform practiceAmit Goyal, David Dodwell, Malcolm W Reed, et al.
BMJ (Clinical Research Ed.)|May 19, 2018
Should patients with ductal carcinoma in situ be treated with adjuvant whole breast radiotherapy after breast conservation surgery?Jessamy Bagenal, Nicola Roche, Gill Ross, et al.
Breast (Edinburgh, Scotland)|March 16, 2005
The oligometastatic state in breast cancer: hypothesis or realityCatherine R Tait, Alison Waterworth, Juliette Loncaster, et al.
Breast Cancer Research and Treatment|February 17, 2010
Aromatase inhibitor-induced arthralgia in early breast cancer: what do we know and how can we find out more?Omar S Din, David Dodwell, Richard J Wakefield, et al.
The Lancet. Oncology|November 5, 2020
Residual disease after mastectomyNigel J Bundred, David Dodwell, James R Bundred, et al.
Journal of Geriatric Oncology|July 8, 2023
Patterns of chemotherapy use and outcomes in advanced non-small cell lung cancer by age in England: A retrospective analysis of the population-based Systemic Anti-Cancer Treatment (SACT) datasetSophie Pilleron, Eva J A Morris, David Dodwell, et al.
NPJ Breast Cancer|March 30, 2025
Mapping the current landscape of locoregional therapy de-escalation trials in early breast cancer: a systematic reviewAlan D McCrorie, Hilary Stobart, David Dodwell, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|January 21, 2026
Reducing locoregional treatments in low risk early invasive breast cancerShelley Potter, Mairead MacKenzie, Stuart McIntosh, et al.
Pageof 12